Acasti Pharma
ACST
$2.78
Share price
3.73%
Change (1 day)
504.35%
Change (1 year)
Categories
Operating Margin for Acasti Pharma (ACST)
Operating Margin as of May 2024 (TTM): -10,039.80%
According to Acasti Pharma 's latest financial reports and stock price the company's current Operating Margin is -10,039.80%. At the end of 2021 the company had an Operating Margin of -10,039.80%.
Operating Margin history for Acasti Pharma from 2011 to 2016
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -10,039.80% | |
| 2016 | -16,774.83% | 2643.37% |
| 2015 | -611.47% | -73.62% |
| 2014 | -2,318.27% | 143.59% |
| 2013 | -951.73% | -81.5% |
| 2012 | -5,143.92% | -38.71% |
| 2011 | -8,393.17% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Omeros Corporation OMER | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.